Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project (GLADLY)

19 januari 2021 uppdaterad av: Andres Camacho-Gonzalez, Emory University
This study aims to understand the barriers to receiving HIV testing and retention of care for at risk and HIV positive young adults. This study also seeks to determine the feasibility and acceptability of HIV testing in a non-clinical setting.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

This study aims to identify factors that can facilitate or impede the use of non-clinical HIV testing venues as well as identify potential testing sites and assess acceptability of an HIV prevention intervention. In addition, the study will implement a pilot intervention to test the feasibility non-clinical HIV testing and follow up events for HIV positive youth.

Studietyp

Interventionell

Inskrivning (Faktisk)

2

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Georgia
      • Atlanta, Georgia, Förenta staterna, 30303
        • Grady Health System
      • Atlanta, Georgia, Förenta staterna, 30308
        • Ponce De Leon Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 24 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Sexually active
  • HIV positive or negative
  • Latino youth ages 18-24 years
  • Residents of the state of Georgia and can understand spoken and written English or Spanish.

Exclusion Criteria:

  • Unmet inclusion criteria

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Icke-randomiserad
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Focus Group
Participants will complete a questionnaire and will be involved in a group discussion regarding good sites within the community to perform HIV testing.
Övrig: Venue Testing Group- Negative Test
Participants will perform a rapid HIV test and will be asked to answer questions about their sexual life and living situation. No followup is needed for a negative HIV test.
A small survey will be conducted to identify risk factors and assess demographics. Participants will receive psychological support and counseling on reducing risk behavior for one year.
Övrig: Venue Testing Group- Positive Test
Participants will perform a rapid HIV test and will be asked to answer questions about their sexual life and living situation. Participants with a positive HIV test will receive care from a psychologist and case manager for one year.
A small survey will be conducted to identify risk factors and assess demographics. Participants with a positive HIV test will receive standard HIV care, support, and guidance from a psychologist and case manager including an assessment of basic needs (food, clothing, shelter), and counseling on risk taking behaviors for one year.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Days to Linkage to Care
Tidsram: Post Diagnosis (Up to 3 months)
For participants who test positive, linkage to care is measured as the number of days to seek HIV treatment.
Post Diagnosis (Up to 3 months)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Number of medical care visits
Tidsram: Post Diagnosis (Up to one year)
For participants who test positive, engagement to care is measured as the number of medical care visits in a six month period after diagnosis. One HIV medical care visit every six months is considered engaged.
Post Diagnosis (Up to one year)
Change in CD4 count
Tidsram: Baseline (Post Diagnosis), One year assessment (Up to one year)
A CD4 count is a lab test that measures the number of CD4 T lymphocytes (CD4 cells) in a blood sample. A very low CD4 count (less than 200 cells/mm3) is a way to determine whether an HIV infection has progressed. Change is measured as the difference in CD4 count from baseline to the end of the study period.
Baseline (Post Diagnosis), One year assessment (Up to one year)
Change in viral load
Tidsram: Baseline (Post Diagnosis), One year assessment (Up to one year)
A viral load test is a lab test that measures the number of HIV virus particles in a milliliter of blood. A high viral load indicates the presence of more HIV within the body. Change is measured as the difference in viral load from baseline to the end of the study period.
Baseline (Post Diagnosis), One year assessment (Up to one year)
Rate of venue acceptance
Tidsram: One year assessment (Up to one year)
The rate of venue acceptance is measured as the number of venues that allow rapid HIV testing over he number of venues approached.
One year assessment (Up to one year)
Rate of study subject acceptance
Tidsram: One year assessment (Up to one year)
The rate of study subject acceptance is measured as the number of participants who agree to participate in rapid HIV testing over the number of people approached.
One year assessment (Up to one year)
Change in HIV stigma scale score
Tidsram: Baseline (Post Diagnosis), One year assessment (Up to one year)
The HIV stigma scale is a ten question self report measure that assesses perceived feelings of being stigmatized. Answers are reported on a scale from 0 (not at all) to 4 (extremely). A higher score indicates feelings of greater stigmatization.
Baseline (Post Diagnosis), One year assessment (Up to one year)
Change in HIV-AIDS stress scale score
Tidsram: Baseline (Post Diagnosis), One year assessment (Up to one year)
The HIV-AIDS stress scale is a self report measure that assesses perceived emotional stress related to HIV. Answers are reported on a scale from 0 (not at all) to 4 (extremely). A higher score indicates more emotional stress.
Baseline (Post Diagnosis), One year assessment (Up to one year)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Andres Camacho-Gonzalez, Emory University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 augusti 2015

Primärt slutförande (Faktisk)

1 augusti 2017

Avslutad studie (Faktisk)

1 augusti 2017

Studieregistreringsdatum

Först inskickad

24 september 2015

Först inskickad som uppfyllde QC-kriterierna

25 september 2015

Första postat (Uppskatta)

29 september 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

22 januari 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

19 januari 2021

Senast verifierad

1 januari 2021

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • IRB00080817

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera